Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parry

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
Canadian Journal of Surgery. Journal Canadien De Chirurgie|October 3, 2020
Patterns of complex emergency general surgery in CanadaKelly N Vogt, Laura Allen, Patrick B Murphy, et al.
Human Gene Therapy|January 1, 1997
A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factorG Dranoff, R Soiffer, T Lynch, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1997
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK A Ellem, M G O'Rourke, G R Johnson, et al.
Neurology|April 11, 2001
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosisR G Miller, D H Moore, D F Gelinas, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanomaR Soiffer, T Lynch, M Mihm, et al.
Journal of Clinical Medicine|February 24, 2024
Are Surgeons Going to Be Left Holding the Bag? Incisional Hernia Repair and Intra-Peritoneal Non-Absorbable Mesh Implant ComplicationsAndrew W Kirkpatrick, Federico Coccolini, Matti Tolonen, et al.
JAMA Network Open|September 22, 2025
Factors in the Initial Resuscitation of Patients With Severe Trauma: The FiiRST-2 Randomized Clinical TrialLuis T da Luz, Keyvan Karkouti, Jo Carroll, et al.
World Journal of Emergency Surgery : WJES|July 7, 2018
Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trialAndrew W Kirkpatrick, Federico Coccolini, Luca Ansaloni, et al.
Elife|September 24, 2024
Identification of pharmacological inducers of a reversible hypometabolic state for whole organ preservationMegan M Sperry, Berenice Charrez, Haleh Fotowat, et al.
World Journal of Emergency Surgery : WJES|May 11, 2023
The unrestricted global effort to complete the COOL trialAndrew W Kirkpatrick, Federico Coccolini, Matti Tolonen, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Canadian Journal of Surgery. Journal Canadien De Chirurgie|October 3, 2020
Patterns of complex emergency general surgery in CanadaKelly N Vogt, Laura Allen, Patrick B Murphy, et al.
Human Gene Therapy|January 1, 1997
A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factorG Dranoff, R Soiffer, T Lynch, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1997
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK A Ellem, M G O'Rourke, G R Johnson, et al.
Neurology|April 11, 2001
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosisR G Miller, D H Moore, D F Gelinas, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanomaR Soiffer, T Lynch, M Mihm, et al.
Journal of Clinical Medicine|February 24, 2024
Are Surgeons Going to Be Left Holding the Bag? Incisional Hernia Repair and Intra-Peritoneal Non-Absorbable Mesh Implant ComplicationsAndrew W Kirkpatrick, Federico Coccolini, Matti Tolonen, et al.
JAMA Network Open|September 22, 2025
Factors in the Initial Resuscitation of Patients With Severe Trauma: The FiiRST-2 Randomized Clinical TrialLuis T da Luz, Keyvan Karkouti, Jo Carroll, et al.
World Journal of Emergency Surgery : WJES|July 7, 2018
Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trialAndrew W Kirkpatrick, Federico Coccolini, Luca Ansaloni, et al.
Elife|September 24, 2024
Identification of pharmacological inducers of a reversible hypometabolic state for whole organ preservationMegan M Sperry, Berenice Charrez, Haleh Fotowat, et al.
World Journal of Emergency Surgery : WJES|May 11, 2023
The unrestricted global effort to complete the COOL trialAndrew W Kirkpatrick, Federico Coccolini, Matti Tolonen, et al.
Pageof 29